Johnson & Johnson’s pharmaceuticals subsidiary Janssen is walking away from plans to launch an HIV vaccine in the immediate future after the data safety monitoring board...
31.10.2018
- An antiviral pill taken daily by thousands of HIV-positive men in Australia has led to a “globally unprecedented” reduction in new infections, according to what is being called...
29.11.2017
- The US Food and Drug Administration (FDA) has approved a new two-drug regimen for HIV that reports suggest could shake up the $22 billion market for products to treat the immune...
28.04.2016
- French biotechnology company Abivax has signed a contract with API manufacturer PCAS group for the production and supply of ABX464, a drug candidate for treating HIV. Under the...
11.11.2015
- The US Food and Drug Administration (FDA) has approved Gilead Sciences’ Genvoya to treat HIV-1 infection. Genvoya combines four treatments – elvitegravir, cobicistat, emtricitabine...
06.11.2015
- GlaxoSmithKline (GSK) is expecting to file 20 new drugs by 2020, with another 20 to follow in the following five years. In a presentation to investors in New York, CEO Andrew Witty...
07.10.2015
- Kemal Malik, board member for innovation at the German Bayer Group, sees many similarities in the genetic system of humans, animals and plants. This opens the door for synergies in...
27.07.2015
- The US Food and Drug Administration has designated the Bristol-Mayers Squibb experimental HIV drug BMS-663068 as a breakthrough treatment, which could accelerate its approval. The...
